Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Dealing with cancer recurrence 

Dealing with cancer recurrence
Chapter:
Dealing with cancer recurrence
Author(s):

Lidia Schapira

and Lauren Goldstein

DOI:
10.1093/med/9780198736134.003.0020
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 February 2020

When patients conclude active cancer therapy, many experience an elevated degree of awareness and worry about disease recurrence. For most patients, this anxiety is intermittent and tolerable, but for others, it is quite disruptive. Patients’ psychological and cognitive difficulties are not systematically explored during routine medical visits. Receiving the news of cancer recurrence is enormously difficult and so is the disclosure of news for the oncologist. The chapter provides practical tips for disclosing prognostic information. Physicians can and should pay particular attention to patients’ overall quality of life, rather than focusing solely on the medical reality, and strive to balance their own communicative preferences and strategies with the needs of their patients, tailoring their process of disclosing news of recurrence to patients’ expressed preferences in order to facilitate coping and sustain the therapeutic alliance.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.